Suzhou LinaTech Medical Science and Technology Co.,Ltd.

LinaTech is a leading manufacturer of medical devices and software for cancer treatment via radiotherapy. Headquartered in Sunnyvale, California, the company designs and produces medical linear accelerators (LINACs), treatment planning systems, image-guided radiation therapy (IGRT) equipment, and multi-leaf collimators for comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. The VenusX Medical Linear Accelerator, FDA-approved, supports 3D Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) with kV-CBCT and MV-EPID imaging guidance. LinaTech's proprietary Monte Carlo-based treatment planning and AI-driven quality assurance streamline clinical workflows and enhance treatment precision. The TiGRT MLC-CC51 add-on system enables stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) capabilities on existing LINAC platforms, extending applicability to intracranial, lung, liver, prostate, and pancreatic cancer treatment. With global service infrastructure spanning US, Europe, and Asia, LinaTech supports approximately 300 users worldwide.